UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
+$21.9B |
| 2 |
Amazon
AMZN
|
+$15.2B |
| 3 |
NVIDIA
NVDA
|
+$4.85B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.03B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.67B |
Top Sells
| 1 |
Microsoft
MSFT
|
+$26B |
| 2 |
Equinix
EQIX
|
+$803M |
| 3 |
NetEase
NTES
|
+$723M |
| 4 |
Digital Realty Trust
DLR
|
+$699M |
| 5 |
Bank of New York Mellon
BK
|
+$653M |
Sector Composition
| 1 | Technology | 31.92% |
| 2 | Financials | 13.89% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.69% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
First Commonwealth Financial
FCF
$1.84B
| $5.35M | ﹤0.01% |
329,347
+86,379
| +36% | +$1.4M |
|
1677
Vanguard Real Estate ETF
VNQ
$34.8B
| $5.33M | ﹤0.01% |
+59,861
| New | +$5.33M |
|
1678
St. Joe Company
JOE
$3.01B
| $5.31M | ﹤0.01% |
111,411
+23,805
| +27% | +$1.14M |
|
1679
Viasat
VSAT
$4.1B
| $5.31M | ﹤0.01% |
363,615
+111,149
| +44% | +$1.62M |
|
1680
S&T Bancorp
STBA
$1.5B
| $5.31M | ﹤0.01% |
140,292
+35,455
| +34% | +$1.34M |
|
1681
Supernus Pharmaceuticals
SUPN
$2.55B
| $5.29M | ﹤0.01% |
167,692
+59,903
| +56% | +$1.89M |
|
1682
Par Pacific Holdings
PARR
$1.67B
| $5.28M | ﹤0.01% |
199,097
+52,856
| +36% | +$1.4M |
|
1683
Vita Coco
COCO
$2.25B
| $5.28M | ﹤0.01% |
146,156
+36,720
| +34% | +$1.33M |
|
1684
MillerKnoll
MLKN
$1.4B
| $5.24M | ﹤0.01% |
269,959
+72,027
| +36% | +$1.4M |
|
1685
Apellis Pharmaceuticals
APLS
$3.14B
| $5.23M | ﹤0.01% |
301,939
+79,305
| +36% | +$1.37M |
|
1686
Symbotic
SYM
$5.32B
| $5.22M | ﹤0.01% |
134,446
+49,547
| +58% | +$1.92M |
|
1687
Andersons Inc
ANDE
$1.38B
| $5.21M | ﹤0.01% |
141,900
+101,406
| +250% | +$3.73M |
|
1688
Macerich
MAC
$4.58B
| $5.21M | ﹤0.01% |
322,100
-4,275
| -1% | -$69.2K |
|
1689
Legend Biotech
LEGN
$6.11B
| $5.19M | ﹤0.01% |
146,322
+32,867
| +29% | +$1.17M |
|
1690
Alphatec Holdings
ATEC
$2.26B
| $5.19M | ﹤0.01% |
467,754
+201,847
| +76% | +$2.24M |
|
1691
Sylvamo
SLVM
$1.75B
| $5.17M | ﹤0.01% |
103,188
+28,296
| +38% | +$1.42M |
|
1692
Veeco
VECO
$1.52B
| $5.15M | ﹤0.01% |
253,215
+60,397
| +31% | +$1.23M |
|
|
SOBO
1693
South Bow Corporation
SOBO
$5.8B
| $5.14M | ﹤0.01% |
198,486
-549
| -0.3% | -$14.2K |
|
1694
Newmark Group
NMRK
$3.41B
| $5.14M | ﹤0.01% |
423,197
+136,894
| +48% | +$1.66M |
|
|
EVRI
1695
DELISTED
Everi Holdings
EVRI
| $5.14M | ﹤0.01% |
360,911
+64,835
| +22% | +$923K |
|
1696
Hillenbrand
HI
$1.73B
| $5.08M | ﹤0.01% |
253,347
+64,500
| +34% | +$1.29M |
|
|
GRAL
1697
GRAIL, Inc. Common Stock
GRAL
$1.37B
| $5.08M | ﹤0.01% |
98,713
+6,248
| +7% | +$321K |
|
1698
Oceaneering
OII
$2.43B
| $5.07M | ﹤0.01% |
244,681
+87,245
| +55% | +$1.81M |
|
1699
Transocean
RIG
$3.11B
| $5.05M | ﹤0.01% |
1,949,741
+680,488
| +54% | +$1.76M |
|
1700
Asana
ASAN
$3.12B
| $5.03M | ﹤0.01% |
372,279
+113,546
| +44% | +$1.53M |
|